Hormone therapy of prostatic carcinoma
Klosterhalfen, H.
Deutsche Medizinische Wochenschrift 102(25): 947
1977
ISSN/ISBN: 0012-0472 PMID: 872769 Document Number: 115901
Document emailed within 1 workday
Related Documents
Studer, U.E. 1995: Advanced prostatic carcinoma--which hormone therapy when? Der Urologe. Ausg. a 34(5): 361-366Ebert, T.; Bendhack, M.L. 1997: Prostatic carcinoma--diagnosis, hormone therapy, radio- and chemotherapy Der Urologe. Ausg. a 36(6): 570-577
Bertelli, A. 1990: Introduction: recent progress in therapy of prostatic carcinoma and other hormone dependent pathology with the use of agonistic analogs of LHRH Drugs under Experimental and Clinical Research 16(Suppl): 1-2
Kumamoto, Y.; Tsukamoto, T.; Umehara, T.; Harada, M.; Shimazaki, J.; Fuse, H.; Oshima, H.; Takeuchi, H.; Yoshida, O.; Okada, K. 1990: Clinical studies on endocrine therapy of prostatic carcinoma (3): Histopathological features of prostatic carcinoma and its prognosis Hinyokika Kiyo. Acta Urologica Japonica 36(3): 295-305
Gez, E.; Ben-Yosef, R.; Libson, E.; Biran, S. 1987: The use of agonist analogues of luteinizing hormone--releasing hormone in the treatment of prostatic carcinoma Harefuah 112(5): 239-241
Strohmenger, P. 1980: Prostatic adenoma--prostatic carcinoma. Questions from general practice. II. Therapy Zfa. Zeitschrift für Allgemeinmedizin 56(28): 1793-1797
Tsukamoto, T.; Fukui, I.; Kihara, K.; Goto, S.; Kitahara, S.; Kobayashi, T.; Kojima, S.; Oshima, H. 1996: Combined hormone-chemotherapy for stage D2 prostatic cancer: starting time of chemotherapy in relation to hormone therapy Hinyokika Kiyo. Acta Urologica Japonica 42(5): 351-356
Smith, P.H.; Akdas, A.; Mason, M.K.; Richards, B.; Robinson, M.R.; de Pauw, M.; Sylvester, R. 1980: Hormone therapy in prostatic cancer Acta Urologica Belgica 48(1): 98-105
Bogdanowicz, J.F.; Bentvelsen, F.M.; Oosterom, R.; Schroeder, F.H. 1991: Evaluation of prostate-specific antigen and prostatic acid phosphatase in untreated prostatic carcinoma and benign prostatic hyperplasia Scandinavian Journal of Urology and Nephrology. Supplementum 138: 97-103
Kattan, J.; Court, B.; Culine, S.; Droz, J.P. 1993: False multiple coin lesions in prostatic cancer under hormone therapy Presse Medicale 22(23): 1104
Geyer, G. 1980: New results in the field of endocrinology with relevance for medical practice. Hyperprolactemia, endocrine adenomatoses, paraneoplastic hormone secretion and hormone therapy of breast carcinoma Wiener Medizinische Wochenschrift 130(15-16): 501-509
Vahlensieck, W.; Tümmers, H.; Tschischak, D. 1974: Diagnosis and therapy of prostatic carcinoma Fortschritte der Medizin 92(30): 1195-1198
Studer, U.E.; Altwein, J.; Bartsch, G. 1991: The potential hormonal therapy of prostatic carcinoma Der Urologe. Ausg. a 30(5): 310-316
Mebust, W.K.; Foret, J.D.; Valk, W.L. 1971: Prostatic carcinoma. Changing concepts of therapy Journal of the Kansas Medical Society 72(3): 124-125
Schmid, H.P. 1995: Possibilities in drug therapy in prostatic carcinoma Therapeutische Umschau. Revue Therapeutique 52(6): 418-422
Reddy, E.K.; Mansfield, C.M. 1982: Prostatic carcinoma. External radiation therapy Journal of the Kansas Medical Society 83(10): 479-483
Leinonen, P.; Hammond, G.L.; Lukkarinen, O.; Vihko, R. 1979: Serum sex hormone binding globulin and testosterone binding after estradiol administration, castration, and their combination in men with prostatic carcinoma Investigative Urology 17(1): 24-27
Studer, U.E.; Münch, D. 1990: Hormonal therapy (medical orchiectomy) in prostatic carcinoma Schweizerische Medizinische Wochenschrift 120(24): 881-887
Weinberg, D.S.; Weidner, N. 1993: Concordance of DNA content between prostatic intraepithelial neoplasia and concomitant invasive carcinoma. Evidence that prostatic intraepithelial neoplasia is a precursor of invasive prostatic carcinoma Archives of Pathology and Laboratory Medicine 117(11): 1132-1137
Ferraris, V.; Pacilli, N.; Bottero, G.; Novella, V.; Pisano, P.F.; Buffa, G. 1994: Treatment of prostatic carcinoma in clinical stage C. Comparison between radiotherapy plus hormonal therapy after progression and immediate hormonal therapy Minerva Urologica e Nefrologica 46(2): 123-128